Geneva-Lausanne School of Pharmacy (EPGL)
Ecole de Pharmacie Genève-Lausanne (EPGL)
Switzerland
1 December 2019 - 30 November 2020
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Geneva-Lausanne School of Pharmacy (EPGL) published between 1 December 2019 - 30 November 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Research collaboration: Geneva-Lausanne School of Pharmacy (EPGL) is a research collaboration whose article contributions are accrued to its participating partner institutions.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 2 | 0.30 |
Outputs by subject (Share)
| Subject | Count | Share | |
|---|---|---|---|
| Life Sciences | 1 | 0.05 | |
| Chemistry | 1 | 0.25 | |
Top articles by Altmetric score in current window
Functional and Computational Genomics Reveal Unprecedented Flexibility in Stage-Specific Toxoplasma Metabolism.
Cell Host & Microbe
2020-01-27
1 December 2019 - 30 November 2020
International vs. domestic collaboration by Share
- 86.84% Domestic
- 13.16% International
Note: Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators by Share (4 total)
- Geneva-Lausanne School of Pharmacy (EPGL), Switzerland
- Domestic institution
Top 10 international collaborators by Share (1 total)
- Geneva-Lausanne School of Pharmacy (EPGL), Switzerland
- Foreign institution
Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.
Participating institutions
Geneva-Lausanne School of Pharmacy (EPGL) is a research collaboration whose article contributions are accrued to its participating partner institutions below.
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
